References: Identifying people suitable for atherosclerotic cardiovascular disease risk estimation

  • Agostino JW, Wong D, Paige E, Wade V, Connell C, Davey ME, et al. Cardiovascular disease risk assessment for Aboriginal and Torres Strait Islander adults aged under 35 years: a consensus statement. Med J Aust 2020;212(9):422-7. https://www.ncbi.nlm.nih.gov/pubmed/32172533
  • Australian Chronic Disease Prevention Alliance. Australian Guideline for assessing and managing cardiovascular disease risk. Melbourne: National Heart Foundation of Australia; 2023. https://www.cvdcheck.org.au/
  • Bell KJ, Hayen A, Irwig L, Takahashi O, Ohde S, Glasziou P. When to remeasure cardiovascular risk in untreated people at low and intermediate risk: observational study. BMJ 2013;346:f1895. https://www.ncbi.nlm.nih.gov/pubmed/23553971
  • Krogsboll LT, Jorgensen KJ, Gotzsche PC. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev 2019;1:CD009009. https://www.ncbi.nlm.nih.gov/pubmed/30699470
  • Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41(1):111-88. https://www.ncbi.nlm.nih.gov/pubmed/31504418
  • Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42(34):3227-337. https://www.ncbi.nlm.nih.gov/pubmed/34458905
  • Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018;39(33):3021-104. https://www.ncbi.nlm.nih.gov/pubmed/30165516